ÂÜÀòÂÒÂ×

NS

Nancy Gasper Smith

Senior Vice President, Medical Writing Services at Syner-G BioPharma Group

Nancy Gasper Smith has extensive work experience in the pharmaceutical and medical writing field. Nancy'smost recent role is as the Senior Vice President of Medical Writing Services at Syner-G BioPharma Group since 2022. Prior to this, they held various positions at Impact Pharmaceutical Services, including Vice President of Medical Writing Services from 2020 to 2022. Nancy also served as a Principal Consultant, Consultant, and Senior Manager at Impact Pharmaceutical Services from 2015 to 2020. Smith's responsibilities during this time included managing medical writing and submissions, quality control, and serving as a lead medical writer on projects such as clinical study reports and New Drug Applications. Before joining Impact Pharmaceutical Services, they worked as a Senior Regulatory and Publications Medical Writer at i3 Statprobe in 2009 and as a Clinical Research Scientist at SRA Global Clinical Development LLC from 2008 to 2009. At SRA Global Clinical Development, they gained experience in project management, regulatory/medical writing, and manuscript and protocol preparation. Smith started their career as a Postdoctoral Research Associate at Duke University Medical Center, where they conducted research in human immunology/virology and was responsible for assay plans, data collection, and manuscript preparation. With a strong background in medical writing, project management, and clinical research, Nancy Gasper Smith brings a wealth of experience to their current position at Syner-G BioPharma Group.

Nancy Gasper Smith completed their education at the University of North Carolina at Charlotte, where they pursued a Ph.D. in Biomedical Technology and Biology from 2002 to 2006. Nancy also obtained a Doctor of Philosophy (Ph.D.) degree in Biology and Biotechnology during the same period. Additionally, they have acquired two certifications: one from the Bell Leadership Institute, specifically the Achievers program, which they obtained in December 2021, and another certification in Regulatory Affairs from the Regulatory Affairs Professionals Society (RAPS), although the specific month and year of obtaining the latter certification are not provided.

Links